Evidence map›Paper›PMID 28149841›Full record

ArticleAnnals of translational medicine2016

Effects of curcumin on

Vaclav Vetvicka, Jana Vetvickova, Rafael Fernandez-Botran

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Annals of translational medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Anti-Molecules (Basel, Switzerland) · 2025
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Reactive Oxygen Species andAntioxidants (Basel, Switzerland) · 2023
    Review
  9. Review
  10. Article
  11. Review
  12. Infection and drug resistance · 2022
    Review
  13. Article
  14. Revisiting Therapeutic Strategies forMolecules (Basel, Switzerland) · 2021
    Review
  15. Survival and Control ofFrontiers in cellular and infection microbiology · 2020
    Review
  16. Curcumin: A Potent Protectant against Esophageal and Gastric Disorders.International journal of molecular sciences · 2019
    Review
  17. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Vaclav VetvickaDepartment of Pathology, University of Louisville, Louisville, KY, USA.
Jana VetvickovaDepartment of Pathology, University of Louisville, Louisville, KY, USA.
Rafael Fernandez-BotranDepartment of Pathology, University of Louisville, Louisville, KY, USA.
University of Louisville · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCurcumin is a well-established natural molecule with significant biological and pharmaceutical effects. Its effects on

methodsUsing a mouse model, we studied the effects of curcumin on lipid peroxide (LPO) level, myeloperoxidase (MPO) and urease activity, number of colonized bacteria, levels of anti-

resultsIn all tests, one sample (Sabinsa) was consistently the most active.

conclusionsAll curcumin samples showed some anti-

Indexed as

BiofilmcurcuminHelicobacter pylori (H. pylori)

Identifiers

PMID28149841
PMCPMC5233496
OpenAlexW2571343759

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.